Humanin
Humanin
A mitochondrial-derived peptide with potent cytoprotective effects. One of the first mitochondrial peptides discovered, showing promise for age-related diseases and metabolic conditions.
Typical Cost
$100-200/vial (10mg)
Status
Research
Peptide Profile
Humanin
Mechanism of Action
Binds to specific receptors on cell surfaces and within mitochondria. Inhibits apoptosis, reduces oxidative stress, and improves mitochondrial function. Activates pro-survival pathways and suppresses inflammatory responses.
Common Dosages
subcutaneous
0.5-2mg
Daily · 4-8 weeks
Benefits
Neuroprotection
Improved insulin sensitivity
Reduced oxidative stress
Anti-apoptotic effects
Metabolic enhancement
Potential longevity benefits
Side Effects
Limited human data
Injection site reactions
Unknown long-term effects
Key Research
Humanin and Alzheimer's disease
Demonstrated neuroprotective effects and improved cognitive markers in Alzheimer's models
Regulatory Status
Research chemical only. Not FDA-approved. Under investigation for Alzheimer's and metabolic diseases.
Contraindications
- ⚠Pregnancy/breastfeeding
- ⚠Active cancer
GLP-1 users focused on longevity and metabolic optimization may consider humanin alongside SeraVia formulations.
Learn More →Find peptide providers
Search 18,000+ clinics offering peptide therapy alongside GLP-1 medications.
Search Providers →Disclaimer: This information is for educational and research purposes only. Peptides described here may not be FDA-approved for human use. Always consult a qualified healthcare provider before using any peptide product. GLP1Search does not sell peptides.